Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Medical Bud News.
Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)
GlobeNewswire, Inc.
·
September 3, 2025
Catalyst for Advancing Discussions with Pharmaceutical Companies that have Expressed Interest in ART27.13 for CACS Consistent Improvements in Weight Gain, Lean Body Mass, and Activity were Observed Across Treated Patients including +6.4% Mean...
Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland
GlobeNewswire, Inc.
·
September 3, 2025
This marks the first export of organic certified flower for SMGH, 20th international market for Aureus branded products and 23rd market for all Avicanna products TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the...
Ethos Cannabis and Thomas Jefferson University to Co-Host Pennsylvania Medical Marijuana Education & Research Summit
GlobeNewswire, Inc.
·
September 2, 2025
As Pennsylvania’s Cannabis Market Evolves, Shapiro Administration Deputy Secretary Meghna Patel and Other Experts Lead Dialogue on Medical Cannabis Policy, Research, and Patient Access Summit to Take Place on September 5, 2025, at Thomas Jefferson...
Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States
GlobeNewswire, Inc.
·
September 2, 2025
re+PLAY is a CBD wellness brand founded by NBA veteran Al Harrington with products utilizing Avicanna’s patented and proprietary CBD formulations. The initial launch of re+PLAY in the United States includes two products available at Harrington...
Antiemetic Drugs Market Poised for Strong Growth Amid Rising Cancer & Chemotherapy Cases Worldwide 2025
EIN Presswire
·
September 2, 2025
The Global Antiemetic Drugs Market is expected to grow at a CAGR of 5.5% during the forecast period (2025-2033). AUSTIN, TX, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- DataM Intelligence — The Global Antiemetic Drugs Market,...
Hospital Microbiology Testing Market to Double by 2032: Driven by Rising Infectious Diseases and Diagnostic Innovation
EIN Presswire
·
September 1, 2025
Hospital Microbiology Testing Market Size is valued at 6.00 billion in 2024 and is expected to reach 13.65 billion by 2032 at a 10.81% CAGR forecast 2025-2032. WILMINGTON, DE, UNITED STATES, September 1, 2025 /EINPresswire.com/ -- Hospital...
Cannabidiol Pet Market Set to Soar to USD 1.6 Billion by 2034, Driven by Pet Wellness Trends
EIN Presswire
·
August 25, 2025
Discover the growing Cannabidiol (CBD) Pet Market driven by rising pet wellness trends, humanization, regulatory support, and innovative, sustainable product VANCOUVER, BC, CANADA, August 25, 2025 /EINPresswire.com/ -- The Cannabidiol (CBD) Pet...
Sleep Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights
EIN Presswire
·
August 25, 2025
The Business Research Company’s Sleep Industry Analysis Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 25, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market...
MAPS Partners with Changemark to Advance Cannabis PTSD Research for Veterans
GlobeNewswire, Inc.
·
August 27, 2025
MAPS takes critical step toward beginning formal site selection and recruitment for MJP2, a Phase 2 study of inhaled cannabis for PTSD in Veterans MAPS selects Changemark Research + Evaluation as Contract Research Organization Women-owned and led...
Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder
GlobeNewswire, Inc.
·
August 26, 2025
MELBOURNE, Australia and NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”) is pleased to report positive data from its Phase 2 clinical trial of PSX-001 (formerly Psi-GAD), a...
Artelo Biosciences Announces New Data from an Initial Food Effect Investigation with ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain
GlobeNewswire, Inc.
·
August 25, 2025
Safety and Pharmacokinetic Data Support Dosing of ART26.12 in Fed or Fasted Conditions Completion of Positive Single Ascending Dose Study with a Preliminary Food Effect Assessment Advances ART26.12 Toward Multiple Ascending Dose Trial SOLANA...
Nukhufest Unveils Full Lineup For 10th Annual Film Festival In NYC
EIN Presswire
·
September 3, 2025
Nukhufest marks 10 years with audience-curated Top 10 finalists, a free NYC screening Sept 27, and a $3,000 Development-to-Distribution grant. NEW YORK, NY, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Nukhufest has announced its full...
THCA Flower, Concentrates, & THC Gummies Shine in Black Tie CBD’s 2025 Product Spotlight
GlobeNewswire, Inc.
·
August 20, 2025
BROWNS SUMMIT, N.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Black Tie CBD, a leader in premium hemp-derived products, proudly unveils its 2025 product spotlight—an expertly curated lineup that showcases the very best across four top categories: THCA...
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
GlobeNewswire, Inc.
·
August 12, 2025
New York, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Cannabinoids are specific chemical compounds found in cannabis, such as...
Global Cannabis Market Outlook 2025–2030: Rising Demand for Edibles, THC, and CBD Products
GlobeNewswire, Inc.
·
August 19, 2025
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to a research report published by MarketsandMarkets "Cannabis Market by Compound Type (THC-dominant, CBD-dominant, Balanced THC & CBD), Product Type (Flowers/Buds, Oil/Tinctures,...
Cardiac Arrhythmia Monitoring Devices Market Projected to Reach $12.5 billion, with a Robust 7.38% CAGR Till 2035
EIN Presswire
·
September 3, 2025
The demand for effective and convenient diagnostic and monitoring solutions for cardiac conditions has intensified NEW YORK, NY, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- According to a comprehensive analysis by Market Research...
Horizon Specialty Seeds to Showcase Certified Hemp and Flax Varieties at NDSU Fiber Roundtable, August 20
EIN Presswire
·
August 13, 2025
Horizon Specialty Seeds, a leading certified flax and hemp seed provider, will participate in the 2025 NDSU Fiber Roundtable and Hemp & Flax Fiber Tour. CLARK, SD, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Horizon Specialty Seeds, a...
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare...
Diverse Biotech Inc. Receives Landmark USPTO Patent Allowance for Disruptive Dual-Action Therapeutic Class
EIN Presswire
·
September 1, 2025
This Novel Patent Opens up new Class of Drugs Signaling Significant and Untouched Market Opportunity in Disease Treatment MIAMI, FL, UNITED STATES, September 1, 2025 /EINPresswire.com/ -- Diverse Biotech Inc., a pioneering biopharmaceutical...
Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
GlobeNewswire, Inc.
·
August 8, 2025
MELBOURNE, Australia and NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for prevalent medical conditions, today announced new...